The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Varenicline (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 29 Jan 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 29 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Dec 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.